期刊文献+

难溶性药物注射给药系统的研究进展 被引量:7

Advances for Parenteral Delivery of Slightly Water-soluble Drugs
原文传递
导出
摘要 由于高通量筛选技术在药物开发上的广泛应用,涌现了越来越多水难溶性的新化合物。注射剂在临床治疗中发挥着重要的作用,但水溶性低却成了这些化合物开发成注射剂的一个主要难题。本文综述了微乳、亚微乳、前药、环糊精包合物、纳米混悬剂和聚合物胶束系统等在难溶性药物注射给药方面的应用,以期能通过比较各给药系统的优缺点,为产品的开发提供思路。 An increasing number of slightly water-soluble new chemical compounds have been generated,with the widespread application of high-throughput screening technology in drug discovery.Injections are of great importance in clinical therapy.However,their poor solubility represents a major challenge for formulation of these compounds in parenteral drug delivery.This paper reviews the application for parenteral delivery systems of slightly water-soluble drugs,including microemulsions,submicron emulsions,prodrugs,nanosuspensions,cyclodextrin inclusion compounds and polymeric micelles.We are trying to provide some ideas for product development by comparing both advantages and disadvantages of various systems.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2010年第11期856-863,共8页 Chinese Journal of Pharmaceuticals
基金 上海市优秀学科带头人计划(08XD14225) 上海市纳米科技专项(0952nm04500) 国家“重大新药创制”科技重大专项资助(2009ZX09301-007)
关键词 微乳 亚微乳 前药 环糊精包合物 纳米混悬剂 聚合物胶束 难溶性药物 综述 microemulsion submicron emulsion prodrug cyclodextrin inclusion compound nanosuspension polymeric micelle slightly water-soluble drug review
  • 相关文献

参考文献32

  • 1Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J]. Adv Drug Deliv Rev, 2001, 46 (1-3) : 3-26.
  • 2Augustijns P, Brewster ME, Kipp JE. Solvent Systems and Their Selection in Pharmaceutics and Biopharmaceutics (Biotechnology: Pharmaceutical Aspects). Chapter 10. Solubilizing Systems for Parenteral Formulation Development [M]. New York: Springer, 2007: 309-339.
  • 3Nornoo AO, Osborne DW, Chow DS. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis [J]. lnt JPharm, 2008, 349(1-2): 108-116.
  • 4Hwang SR, Lim S J, Park JS, et al. Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration [J]. Int J Pharm, 2004, 276 (1-2): 175-183.
  • 5Wang JP, Takayama K, Nagai T, et al. Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol [J]. IntJPharm, 2003, 251 (1-2) : 13-21.
  • 6蔡伟惠,金方.不同丙泊酚载药体系中游离药物浓度与体外溶血性的关系[J].中国医药工业杂志,2008,39(1):22-27. 被引量:6
  • 7Muller RH, Schmidt S, Buttle I, et al. SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs [J]. lntJPharm, 2004, 269 (2) : 293-302.
  • 8Li F, Wang T, He HB, et al. The properties of bufadienolides- loaded nano-emulsion and submicro-emulsion during lyophilization [J]. Int J Pharm, 2008, 349 (1-2) : 291-299.
  • 9Struys MM, Vanluchene AL, Gibiansky E, et al. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 2) : pharmacodynamics and safety EJ]. Anesthesiology, 2005, 103 (4) : 730-743.
  • 10Kimura T, Kashiwase S, Makimoto A, et al. Pharmacokinetic and pharmacodynamic investigation of irinotecan hydrochloride in pediatric patients with recurrent or progressive solid tumors [J]. Int J Clin Pharmacol Ther, 2010, 48(5): 327-334.

二级参考文献7

  • 1张利勇,王威,王保国.丙泊酚不良反应的多中心和大样本调查[J].首都医科大学学报,2006,27(2):255-257. 被引量:22
  • 2Trapani A, Laquintana V, Lopedota A, et al. Evaluation of new propofol aqueous solutions for intravenous anesthesia [J]. IntJPharm, 2004, 278 (1) : 91-98.
  • 3Morey TE, Modell JH, Shekhawat D, et al. Preparation and anesthetic properties of propofol microemulsions in rats [J]. Anesthesiology, 2006, 104 (6) : 1184-1190.
  • 4Yamakage M, Iwasaki S, Satoh J, et al. Changes in concentrations of free propofol by modification of the solution [J]. AneshAnalg, 2005, 101 (2) : 385-388.
  • 5Müller RH, Hamisch S. Physicochemical characterization of propofol-loaded emulsions and interaction with plasma proteins [J]. Eur Hosp Pharm, 2000, 6:24-31.
  • 6《中药、天然药物刺激性和溶血性研究的技术指导原则》课题研究组.中药、天然药物刺激性、过敏性和溶血性研究技术指导原则[S].北京:国家食品药品监督管理局药品审评中心,2005.22-25.
  • 7Jumaa M, Muller BW. Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect [J]. Eur J Pharm Sci, 2000, 9 (3) : 285-290.

共引文献5

同被引文献92

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部